Specific immunotherapy in asthma: a comprehensive review (Q38161996)

30 August 2017

title

Specific immunotherapy in asthma: a comprehensive review (English)

1 reference

30 August 2017

0 references

1 reference

1

Giovanni Passalacqua

1 reference

30 August 2017

language of work or name

English

0 references

publication date

13 November 2013

1 reference

30 August 2017

1 reference

30 August 2017

volume

51

1 reference

30 August 2017

issue

1

1 reference

30 August 2017

page(s)

29-33

1 reference

Pearls and pitfalls of allergy diagnostic testing: report from the American College of Allergy, Asthma and Immunology/American Academy of Allergy, Asthma and Immunology Specific IgE Test Task Force

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Recommendations for standardization of clinical trials with Allergen Specific Immunotherapy for respiratory allergy. A statement of a World Allergy Organization (WAO) taskforce.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Specific immunotherapy in asthma: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Allergen immunotherapy: A practice parameter third update

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

The efficacy of sublingual immunotherapy for house dust mites respiratory allergy: results of a GA2LEN meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Impact of sublingual immunotherapy on seasonal asthma and skin reactivity in children allergic to Parietaria pollen treated with inhaled fluticasone propionate

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Fatalities from immunotherapy (IT) and skin testing (ST)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Evaluation of near-fatal reactions to allergen immunotherapy injections

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Immunotherapy: a one-year prospective study to evaluate risk factors of systemic reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Comparison of allergen immunotherapy practice patterns in the United States and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Immunotherapy safety: a prospective multi-centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Sublingual immunotherapy: a comprehensive review.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Sublingual allergen immunotherapy: mode of action and its relationship with the safety profile

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Safety of a SQ-standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Rhinitis and onset of asthma: a longitudinal population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Specific immunotherapy: beyond the clinical scores

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109/02770903.2013.853082

10.3109/02770903.2013.853082

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference